Common triggers for food protein-induced enterocolitis syndrome (FPIES) have shifted, and more cases than expected have ...
Omalizumab is superior to oral immunotherapy (OIT) for multifood allergy, and most patients include dietary consumption (DC) ...
The study of success eating food triggers after stopping Xolair is ongoing, so researchers are still collecting data for doctors to use making treatment plans with their patients. Parents interested ...
Omalizumab was found to be more effective than multi-allergen oral immunotherapy (OIT) in reducing allergic reactions in patients with 1 or more food allergies, according to results from Stage 2 of ...
Roche’s asthma drug Xolair appears to be safer and more effective than oral immunotherapy at treating adults and children ...
Infants exclusively breastfed in the first 3 days of life had fewer food allergies at 1 year of age than those who also got ...
Omalizumab works by binding to the allergy-causing antibody called immunoglobulin E in the blood and preventing it from ...
Immunoglobulin G hypogammaglobulinemia was found in 44.7% of patients with acute exacerbations of COPD receiving triple ...
Pharvaris (PHVS) highlighted safety and efficacy data of deucrictibant, which is currently being evaluated in two pivotal Phase 3 studies, ...
A new study has revealed that the injectable asthma drug helped more than one-third of the kids to overcome their food ...
Infants who did not exclusively feed on colostrum during their first 3 days of life were more likely to develop egg or peanut ...